1 Ocak 2011 Dergi makalesi Açık Erişim

Celikyurt, Ipek Komsuoglu; Kayir, Hakan; Ulak, Guner; Erden, Faruk B.; Ulusoy, Gokhan K.; Uzbay, Tayfun I.

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
    <subfield code="o">oai:zenodo.org:20797</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Comorbid substance use in schizophrenic patients is common, and substance dependence is a predictive factor for psychosis. The present study was designed to investigate the effects of risperidone, quetiapine and ziprasidone, atypical antipsychotic drugs, on ethanol withdrawal syndrome (EWS) in rats. Adult male Wistar rats were used in the study. Ethanol (7.2%, v/v) was given to rats via a liquid diet for 21 days. An isocaloric liquid diet without ethanol was given to control rats. Risperidone (1 and 2 mg/kg), quetiapine (8 and 16 mg/kg), ziprasidone (0.5 and 1 mg/kg) and vehicle were injected into rats intraperitoneally at 1.5 and 5.5 h of ethanol withdrawal. At the 2nd, 4th and 6th hours of ethanol withdrawal, rats were observed for 5 min, and withdrawal signs that included locomotor hyperactivity, stereotyped behaviors, abnormal gait and posture, tail stiffness and agitation were recorded or rated. Following the observations at the 6th hour, the rats were tested for audiogenic seizures. All three drugs had some significant inhibitory effects on EWS-induced behavioral signs beginning at the 2nd hour of withdrawal. The drugs also significantly reduced the incidence of audiogenic seizures. Overall, risperidone and quetiapine seemed to be more effective than ziprasidone in ameliorating the withdrawal signs. Doses of the drugs used in the present study did not produce any significant changes in locomotor activities of naive rats. Our results suggest that risperidone, quetiapine and ziprasidone had beneficial effects on EWS in rats. Thus, these drugs may be helpful for controlling withdrawal signs in ethanol-dependent patients. (C) 2010 Elsevier Inc. All rights reserved.</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Celikyurt, Ipek Komsuoglu</subfield>
    <subfield code="u">Kocaeli Univ, Fac Med, Dept Pharmacol, Izmit, Turkey</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="z">md5:b98014a73d6e488564f5936055a0e4e1</subfield>
    <subfield code="s">246</subfield>
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/20797/files/bib-fa674247-d2bf-4c11-8608-86f86f5dcf4b.txt</subfield>
  </datafield>
  <controlfield tag="005">20210315104007.0</controlfield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2011-01-01</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1016/j.pnpbp.2010.12.009</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="v">35</subfield>
    <subfield code="p">PROGRESS IN NEURO-PSYCHOPHARMACOLOGY &amp; BIOLOGICAL PSYCHIATRY</subfield>
    <subfield code="c">528-536</subfield>
    <subfield code="n">2</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kayir, Hakan</subfield>
    <subfield code="u">Gulhane Mil Med Acad, Fac Med, Dept Med Pharmacol, Psychopharmacol Res Unit, TR-06018 Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ulak, Guner</subfield>
    <subfield code="u">Kocaeli Univ, Fac Med, Dept Pharmacol, Izmit, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Erden, Faruk B.</subfield>
    <subfield code="u">Kocaeli Univ, Fac Med, Dept Pharmacol, Izmit, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ulusoy, Gokhan K.</subfield>
    <subfield code="u">Gulhane Mil Med Acad, Fac Med, Dept Med Pharmacol, Psychopharmacol Res Unit, TR-06018 Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Uzbay, Tayfun I.</subfield>
    <subfield code="u">Gulhane Mil Med Acad, Fac Med, Dept Med Pharmacol, Psychopharmacol Res Unit, TR-06018 Ankara, Turkey</subfield>
  </datafield>
  <controlfield tag="001">20797</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
</record>